Most fillers come in a one-milliliter syringe (the equivalent of a small blueberry, and you need five of those to make one ...

JUVÉDERM ® VOLUMA ® XC is the One and Only Hyaluronic Acid Dermal Filler Indicated to Treat Cheeks, Chin, and Now Moderate to Severe Temple Hollowing 1,2 Only Allergan Aesthetics, the Makers of ...

Following its U.S. FDA approval in March 2024, JUVÉDERM® VOLUMA® XC is the first and only hyaluronic acid (HA) filler approved to treat moderate to severe temple hollowing in adults over 21.1,2 ...

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the national availability of JUVÉDERM® VOLUMA® XC for temple hollowing. Following its U.S. FDA approval in March 2024, JUVÉDERM® VOLUMA® ...

Penis filler clinics are a booming business for plastic surgeons, despite the fact that the FDA has yet to approve the treatment. One client in New York shares his experience.

Recognized globally for its extensive line of hyaluronic acid dermal fillers, Juvederm, offered by Med Supply Solutions, stands at the forefront of cosmetic treatments designed to combat facial aging.

"The approval of JUVÉDERM ® VOLUMA ® XC to treat temple hollows further demonstrates Allergan Aesthetics commitment to innovation and addressing patient needs," said Carrie Strom, ...

Allergan Aesthetics, an AbbVie company, announced that the FDA has approved Juvéderm Voluma XC to treat moderate to severe temple hollowing in adults over 21 years of age. According to the company, ...